165 related articles for article (PubMed ID: 18248671)
21. Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.
Lv Q; Liu Y; Huang H; Zhu M; Wu J; Meng D
Onco Targets Ther; 2020; 13():5541-5550. PubMed ID: 32606769
[TBL] [Abstract][Full Text] [Related]
22. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
23. A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.
Feoktistova M; Makarov R; Brenji S; Schneider AT; Hooiveld GJ; Luedde T; Leverkus M; Yazdi AS; Panayotova-Dimitrova D
Cells; 2020 Feb; 9(2):. PubMed ID: 32028675
[TBL] [Abstract][Full Text] [Related]
24. A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle.
Shen H; Qu Z; Harata-Lee Y; Cui J; Aung TN; Wang W; Kortschak RD; Adelson DL
Sci Rep; 2019 Nov; 9(1):15889. PubMed ID: 31685921
[TBL] [Abstract][Full Text] [Related]
25. High A20 expression negatively impacts survival in patients with breast cancer.
Yoon CI; Ahn SG; Bae SJ; Shin YJ; Cha C; Park SE; Lee JH; Ooshima A; Lee HS; Yang KM; Kim SJ; Park SH; Jeong J
PLoS One; 2019; 14(8):e0221721. PubMed ID: 31449546
[TBL] [Abstract][Full Text] [Related]
26. PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation.
Michmerhuizen AR; Pesch AM; Moubadder L; Chandler BC; Wilder-Romans K; Cameron M; Olsen E; Thomas DG; Zhang A; Hirsh N; Ritter CL; Liu M; Nyati S; Pierce LJ; Jagsi R; Speers C
Mol Cancer Ther; 2019 Nov; 18(11):2063-2073. PubMed ID: 31413177
[TBL] [Abstract][Full Text] [Related]
27. PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer.
Costa TDF; Zhuang T; Lorent J; Turco E; Olofsson H; Masia-Balague M; Zhao M; Rabieifar P; Robertson N; Kuiper R; Sjölund J; Spiess M; Hernández-Varas P; Rabenhorst U; Roswall P; Ma R; Gong X; Hartman J; Pietras K; Adams PD; Defilippi P; Strömblad S
Nat Commun; 2019 Aug; 10(1):3589. PubMed ID: 31399573
[TBL] [Abstract][Full Text] [Related]
28. Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors.
Hsueh YS; Chang HH; Shan YS; Sun HS; Fletcher JA; Li CF; Chen LT
Oncogene; 2019 Sep; 38(38):6550-6565. PubMed ID: 31363162
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
[TBL] [Abstract][Full Text] [Related]
30. The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan.
Huang CY; Chang WS; Tsai CW; Hsia TC; Shen TC; Bau DT; Shui HA
Medicine (Baltimore); 2018 Sep; 97(36):e12135. PubMed ID: 30200105
[TBL] [Abstract][Full Text] [Related]
31. RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.
Zare A; Petrova A; Agoumi M; Amstrong H; Bigras G; Tonkin K; Wine E; Baksh S
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29874851
[TBL] [Abstract][Full Text] [Related]
32. Hapalindole H Induces Apoptosis as an Inhibitor of NF-ĸB and Affects the Intrinsic Mitochondrial Pathway in PC-3 Androgen-insensitive Prostate Cancer Cells.
Acuña UM; Mo S; Zi J; Orjala J; DE Blanco EJC
Anticancer Res; 2018 Jun; 38(6):3299-3307. PubMed ID: 29848677
[TBL] [Abstract][Full Text] [Related]
33. The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells.
Egusquiaguirre SP; Yeh JE; Walker SR; Liu S; Frank DA
Neoplasia; 2018 May; 20(5):489-498. PubMed ID: 29621649
[TBL] [Abstract][Full Text] [Related]
34. Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells.
Zanotto-Filho A; Rajamanickam S; Loranc E; Masamsetti VP; Gorthi A; Romero JC; Tonapi S; Gonçalves RM; Reddick RL; Benavides R; Kuhn J; Chen Y; Bishop AJR
Cancer Lett; 2018 Jul; 425():101-115. PubMed ID: 29608984
[TBL] [Abstract][Full Text] [Related]
35. T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
Mustafa DAM; Pedrosa RMSM; Smid M; van der Weiden M; de Weerd V; Nigg AL; Berrevoets C; Zeneyedpour L; Priego N; Valiente M; Luider TM; Debets R; Martens JWM; Foekens JA; Sieuwerts AM; Kros JM
Acta Neuropathol; 2018 Apr; 135(4):581-599. PubMed ID: 29350274
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Li Y; Wang Y
Mol Med Rep; 2017 Dec; 16(6):8657-8664. PubMed ID: 28990063
[TBL] [Abstract][Full Text] [Related]
37. A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.
Durand S; Trillet K; Uguen A; Saint-Pierre A; Le Jossic-Corcos C; Corcos L
BMC Genomics; 2017 Sep; 18(1):758. PubMed ID: 28962550
[TBL] [Abstract][Full Text] [Related]
38. The tumor microenvironment and inflammatory breast cancer.
Huang A; Cao S; Tang L
J Cancer; 2017; 8(10):1884-1891. PubMed ID: 28819386
[TBL] [Abstract][Full Text] [Related]
39. Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.
Morrow RJ; Etemadi N; Yeo B; Ernst M
Mediators Inflamm; 2017; 2017():4754827. PubMed ID: 28607534
[TBL] [Abstract][Full Text] [Related]
40. RegulatorTrail: a web service for the identification of key transcriptional regulators.
Kehl T; Schneider L; Schmidt F; Stöckel D; Gerstner N; Backes C; Meese E; Keller A; Schulz MH; Lenhof HP
Nucleic Acids Res; 2017 Jul; 45(W1):W146-W153. PubMed ID: 28472408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
